POS-935 OUTCOME OF COVID-19 IN DIALYSIS PATIENTS IN KELANTAN

Abstract

Introduction Coronavirus disease 2019 (COVID-19)outbreak had occurred since December 2019 and rapidly spread worldwide including Malaysia. Chronic kidney disease and kidney failure are substantial comorbidities that are associated with untoward outcomes in patients with COVID-19. Kidney failure is an independent risk factor for severe COVID-19 disease presentation and mortality after accounting coexisting comorbidities. Therefore, the purpose of this cross sectional analysis is to study outcome of COVID-19 patients on dialysis in Kelantan that will give additional sight for healthcare providers in managing COVID-19. Methods This study is retrospective cross-sectional study. The data collected from 1st April 2020 till 15 April 2021 via patient's record during admission. Aim of this study is to assess outcome of all patients confirm COVID-19 that underwent dialysis durinng admission using perform. The data analysis done using Spss version 25.0. Results shown via descriptive and categorical data. Results In Kelantan, total of 3143 patients admitted for COVID-19 from 1st April 2020 till 15th April 2021. There were 48 (1.5%) patients requiring dialysis during COVID-19 admission. Their demographic data, comorbidities, length of hospital stay, length of Intensive Care Unit stay and discharge or death were collected. All were Malays, mean age was 59.9 years old, 22(45.8%) male patients, 26 (54.2%) were female patients. Among 48 patients on dialysis, 33 (68.8%) patients were End Stage Renal Disease and 15(31.2%) patients were Acute Kidney Injury. Majority of them had Hypertension 95.8%.The mean severity of COVID-19 was Category 4. Mean total length of hospital stay was 13 days. There were 26(54.2%)patients.on dialysis requiring admission to Intensive Care Unit (ICU) ; 14 (53.8%) were ESRD and 12(46.2%) were AKI. There were 10 (30.0%) ESRD patients and 8 (53.3%) AKI patients died due to severe COVID-19 infection. Conclusions COVID-19 infection carries high mortality especially among AKI and ESRD patients. No conflict of interest